Скачать или смотреть New Zealand Halts Puberty Blockers: Gender-Affirming Care Suspended

New Zealand's government has suspended new prescriptions for puberty blockers for gender dysphoria in young people, citing uncertain evidence and adopting a "precautionary approach." This decision follows similar moves in the UK after the Cass Review and mirrors concerns about the long-term effects of these drugs.
Health Minister Simeon Brown announced the change, effective December 19th, stating the need for clinically sound and carefully managed treatments. Existing patients and those using the drugs for other medical conditions will continue to have access.
The decision has sparked debate, with supporters like Winston Peters and Karen Chhour praising it as a victory for science and child safety. Critics, including Green Party MP Ricardo Menéndez March, accuse the government of importing culture wars and targeting trans people. The Professional Association for Transgender Health Aotearoa (PATHA) has criticized the Cass Review as irrelevant to New Zealand.
This video explores the details of the policy change, the arguments on both sides, and the potential impact on young people seeking gender-affirming care in New Zealand.